Nonalcoholic Steatohepatitis (NASH)
WEEKLY NEWSLETTER
Health's Top Stories
Get a weekly look at the most popular stories on Health.com.
Nonalcoholic Steatohepatitis (NASH)
content provided by
Healthwise
Other Treatment
Insulin resistance is a major risk factor for nonalcoholic steatohepatitis (NASH). But medicines that treat insulin resistance, such as thiazolidinediones and metformin, are not proven to be effective specifically for treating NASH. These medicines are currently being studied for their effectiveness in treating NASH.
Damage to liver cells from free radicals is also thought to contribute to NASH. Medicines that prevent this damage, including certain antioxidants and vitamins E and C, have shown in early tests that they may be useful in treating NASH. But the long-term safety and effectiveness of these drugs in treating NASH is still being studied.
PREVIOUS
Last Updated:
July 18, 2007- Author:
- Monica Rhodes
- Medical Review:
- Kathleen Romito, MD - Family Medicine
W. Thomas London, MD - Hepatology
© 1995-2009 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
